🔗 Share this article

This year's Nobel Prize in Physiology or Medicine was awarded for revolutionary discoveries that clarify how the body's defense network attacks dangerous infections while protecting the body's own cells.

A trio of esteemed researchers—from Japan Prof. Sakaguchi and American scientists Dr. Brunkow and Fred Ramsdell—received this honor.

Their work uncovered specialized "security guards" within the defense system that eliminate malfunctioning defense cells capable of attacking the body.

The discoveries are now paving the way for innovative treatments for autoimmune diseases and malignancies.

These winners will divide a monetary award worth 11m SEK.

Crucial Discoveries

"The work has been decisive for comprehending how the immune system functions and why we do not all suffer from serious autoimmune diseases," stated the chair of the Nobel Committee.

This trio's research explain a core mystery: How does the defense system protect us from numerous infections while keeping our own tissues unharmed?

The immune system uses white blood cells that scan for signs of infection, even pathogens and germs it has never encountered.

These cells utilize detectors—called recognition units—that are produced by chance in a vast number of combinations.

This provides the immune system the ability to combat a wide array of threats, but the randomness of the mechanism unavoidably produces immune cells that may target the body.

Protectors of the Immune System

Researchers earlier knew that some of these harmful white blood cells were destroyed in the thymus—where immune cells develop.

This year's award recognizes the identification of T-reg cells—described as the immune system's "security guards"—which patrol the system to neutralize any defenders that assault the healthy cells.

It is known that this process fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee stated, "These findings have laid the foundation for a novel area of investigation and accelerated the development of new therapies, for instance for cancer and immune disorders."

Regarding malignancies, T-regs prevent the body from attacking the growth, so studies are aimed at lowering their quantity.

In self-attack disorders, trials are testing increasing T-reg cells so the organism is not being harmed. A comparable method could also be useful in reducing the risks of transplanted organ failure.

Innovative Experiments

Prof Shimon Sakaguchi, from Osaka University, conducted tests on mice that had their thymus extracted, leading to self-attack conditions.

He demonstrated that introducing defense cells from healthy mice could prevent the disease—implying there was a system for blocking defenders from attacking the host.

Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an genetic immune disorder in rodents and people that resulted in the discovery of a gene vital for how regulatory T-cells function.

"Their groundbreaking work has uncovered how the body's defenses is controlled by regulatory T cells, stopping it from accidentally attacking the healthy cells," said a prominent physiology specialist.

"The research is a remarkable illustration of how basic physiological research can have far-reaching implications for human health."